Prognostic value of c-erbB-2 expression in uterine cervical carcinoma.
AUTOR(ES)
Hale, R. J.
RESUMO
AIMS: To study the pattern of expression and prognostic importance of c-erbB-2 protein in cervical carcinoma. METHODS: Sixty two cases of stage IB/IIA cervical carcinoma, representing the three main tumour types, were investigated immunohistochemically for the presence of c-erbB-2 protein expression, using a monoclonal antibody (CB11) to its internal domain. Follow up of at least five years' duration was available in all cases. RESULTS: Definite membrane staining was seen in 38.7% of cases. There was a strong correlation with poor survival (p less than 0.0001) particularly. For those with adenocarcinomas, this was the case when nodal metastases were present. In contrast, for squamous carcinomas and adenosquamous carcinomas, the association with a poor prognosis was most apparent in those patients without lymph node metastases. CONCLUSIONS: These findings raise the possibility that immunostaining for c-erbB-2 protein could be used as a prognostic marker and may help identify those patients for whom early adjuvant treatment might be beneficial.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=495185Documentos Relacionados
- Lack of c-erbB-2 oncoprotein expression in male breast carcinoma.
- c-erbB-2 oncogene product expression and prognosis in gastric carcinoma.
- c-erbB-2 expression in different histological types of invasive breast carcinoma.
- c-erb-B-2 expression in male breast carcinoma.
- c-erbB-2 overexpression and histological type of in situ and invasive breast carcinoma.
